Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-005263
Filing Date
2022-04-01
Accepted
2022-04-01 08:00:26
Documents
3
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A crbp-proxy-2022.htm DEF 14A 859139
2 GRAPHIC img182928333_0.jpg GRAPHIC 198348
3 GRAPHIC img182928333_1.jpg GRAPHIC 196038
  Complete submission text file 0000950170-22-005263.txt   1384996
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 22795845
SIC: 2834 Pharmaceutical Preparations